Delaware
|
001-35210
|
54-1708481
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS. Employer Identification No.)
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a‑12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d‑2(b) under the Exchange Act (17 CFR 240.14d‑2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e‑4(c) under the Exchange Act (17 CFR 240.13e‑4(c))
|
Item 2.02 | Results of Financial Operations. |
Item 7.01 | Regulation FD Disclosure |
Item 9.01 | Financial Statements and Exhibits |
Press Release of HC2 Holdings, Inc. dated March 15, 2016
|
Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Exchange Act, nor shall it be deemed incorporated by reference in any filing under the Securities Act, except as shall be expressly set forth by specific reference in a filing.
|
HC2 Holdings, Inc.
|
||
Date: March 15, 2016
|
By:
|
/s/ Michael Sena
|
Name:
|
Michael Sena
|
|
Title:
|
Chief Financial Officer
|
• | Net revenue: HC2 recorded consolidated total net revenues of $360.6 million for the fourth quarter of 2015, an increase of $136.6 million, or 61%, as compared to the fourth quarter of 2014, primarily driven by the expansion in scale and number of customer relationships in our Telecommunications segment. |
• | Operating Profit/(Loss): HC2 reported a loss of $3.2 million from operations for the fourth quarter compared to a loss of $6.8 million during the fourth quarter of 2014, primarily driven by a reduction in corporate share-based payment expense due to equity awards granted in the fourth quarter of 2014. |
• | Adjusted EBITDA: Adjusted EBITDA for our Manufacturing, Marine Services, Telecommunications, Utilities, and Insurance segments (our “Core Operating Subsidiaries”), was a combined $26.7 million for the fourth quarter of 2015 and $96.9 million for fiscal year 2015. This compares to a combined Adjusted EBITDA of $94.3 million during fiscal year 2014. |
• | Balance sheet: As of December 31, 2015, HC2 had consolidated cash, cash equivalents and investments of $1.5 billion, which includes the addition of our Insurance segment during the fourth quarter. At the corporate level, HC2 had $41.2 million in cash, cash equivalents and short-term investments at the end of the year. |
• | On December 24, 2015, HC2 completed the acquisition of long-term care and life insurance businesses, United Teacher Associates Insurance Company (“UTAIC”) and Continental General Insurance Company (“CGIC”). UTAIC and CGIC had approximately $80.0 million of statutory surplus and $1.9 billion in total GAAP assets as of December 31, 2015. |
• | Schuff’s backlog was $380.8 million as of December 31, 2015 consistent with the third quarter 2015 backlog. Notable ongoing projects include the Wilshire Grand Center in Los Angeles, the new Apple headquarters in Cupertino, CA, the new Volvo facility in South Carolina, the Anaheim Convention Center, and the Loma Linda Hospital in Los Angeles. |
• | Global Marine announced the acquisition of a majority interest in CWind Limited, a leading offshore renewables specialist, highlighting the continued commitment to the offshore renewable sector. Global Marine also completed operations and installed a fiber optic cable between the Japanese island of Okinawa and an existing branching unit (BU) in the Asia Submarine-cable Express (ASE) system. In addition, Global Marine secured a sub-contract to install an optic cable between the Indonesian islands of Bali and Lombok and a contract win from Ocean Networks Canada, to upgrade the fibre optic cables serving the NEPTUNE observatory off the west coast of Canada. |
•
|
On November 4, 2015, HC2 announced the pricing of an underwritten public offering of 8,452,500 newly issued shares of HC2’s common stock. The net proceeds to HC2 from the offering, after deducting underwriting discounts and commissions and offering expenses, were approximately $54.7 million.
|
December 31,
|
||||||||
2015
|
2014
|
|||||||
Assets
|
||||||||
Investments:
|
||||||||
Fixed maturities, available-for-sale at fair value
|
$
|
1,231,841
|
$
|
250
|
||||
Equity securities, available-for-sale at fair value
|
49,682
|
4,867
|
||||||
Mortgage loans
|
1,252
|
-
|
||||||
Policy loans
|
18,476
|
-
|
||||||
Other invested assets
|
53,119
|
50,566
|
||||||
Total investments
|
1,354,370
|
55,683
|
||||||
Cash and cash equivalents
|
158,624
|
107,978
|
||||||
Restricted cash
|
538
|
6,467
|
||||||
Accounts receivable, net
|
210,853
|
152,279
|
||||||
Costs and recognized earnings in excess of billings on uncompleted contracts
|
39,310
|
28,098
|
||||||
Inventory
|
12,120
|
14,975
|
||||||
Recoverable from reinsurers
|
522,562
|
-
|
||||||
Accrued investment income
|
15,300
|
-
|
||||||
Deferred tax asset
|
52,511
|
15,720
|
||||||
Property, plant and equipment, net
|
214,466
|
233,022
|
||||||
Goodwill
|
61,178
|
30,540
|
||||||
Intangibles
|
29,409
|
31,158
|
||||||
Other assets
|
65,206
|
32,378
|
||||||
Assets held for sale
|
6,065
|
3,865
|
||||||
Total assets
|
$
|
2,742,512
|
$
|
712,163
|
||||
Liabilities, temporary equity and stockholders’ equity
|
||||||||
Life, accident and health reserves
|
$
|
1,593,330
|
$
|
-
|
||||
Annuity reserves
|
259,460
|
-
|
||||||
Value of business acquired
|
50,761
|
-
|
||||||
Accounts payable and other current liabilities
|
225,389
|
147,602
|
||||||
Billings in excess of costs and recognized earnings on uncompleted contracts
|
21,201
|
41,959
|
||||||
Deferred tax liability
|
4,281
|
-
|
||||||
Long-term obligations
|
371,876
|
335,531
|
||||||
Pension liability
|
25,156
|
37,210
|
||||||
Other liabilities
|
17,793
|
1,617
|
||||||
Total liabilities
|
2,569,247
|
563,919
|
||||||
Commitments and contingencies
|
||||||||
Temporary equity:
|
||||||||
Preferred stock, $.001 par value - 20,000,000 shares authorized; Series A - 29,172 and 30,000 shares issued and outstanding at December 31, 2015 and 2014, respectively; Series A-1 - 10,000 and 11,000 shares issued and outstanding at December 31, 2015 and 2014, respectively; Series A-2 - 14,000 and 0 shares issued and outstanding at December 31, 2015 and 2014, respectively
|
52,619
|
39,845
|
||||||
Redeemable noncontrolling interest
|
3,122
|
4,004
|
||||||
Total temporary equity
|
55,741
|
43,849
|
||||||
Stockholders’ equity:
|
||||||||
Common stock, $.001 par value - 80,000,000 shares authorized; 35,281,375 and 23,844,711 shares issued and 35,249,749 and 23,813,085 shares outstanding at December 31, 2015 and 2014, respectively
|
35
|
24
|
||||||
Additional paid-in capital
|
209,477
|
141,948
|
||||||
Accumulated deficit
|
(79,729
|
)
|
(44,164
|
)
|
||||
Treasury stock, at cost
|
(378
|
)
|
(378
|
)
|
||||
Accumulated other comprehensive loss
|
(35,375
|
)
|
(18,243
|
)
|
||||
Total HC2 Holdings, Inc. stockholders’ equity before noncontrolling interest
|
94,030
|
79,187
|
||||||
Noncontrolling interest
|
23,494
|
25,208
|
||||||
Total stockholders’ equity
|
117,524
|
104,395
|
||||||
Total liabilities, temporary equity and stockholders’ equity
|
$
|
2,742,512
|
$
|
712,163
|
Years Ended December 31,
|
||||||||||||
2015
|
2014
|
2013
|
||||||||||
Services revenue
|
$
|
595,280
|
$
|
197,280
|
$
|
230,686
|
||||||
Sales revenue
|
522,661
|
350,158
|
-
|
|||||||||
Life, accident and health earned premiums, net
|
1,578
|
-
|
-
|
|||||||||
Net investment income
|
1,031
|
-
|
-
|
|||||||||
Realized gains (losses) on investments
|
256
|
-
|
-
|
|||||||||
Net revenue
|
1,120,806
|
547,438
|
230,686
|
|||||||||
Operating expenses
|
||||||||||||
Cost of revenue—services
|
544,655
|
177,812
|
220,315
|
|||||||||
Cost of revenue—sales
|
437,968
|
296,530
|
-
|
|||||||||
Insurance benefits and acquisition expenses
|
2,245
|
-
|
-
|
|||||||||
Selling, general and administrative
|
108,527
|
80,239
|
34,692
|
|||||||||
Depreciation and amortization
|
23,280
|
6,334
|
12,032
|
|||||||||
(Gain) loss on sale or disposal of assets
|
170
|
(162
|
)
|
(8
|
)
|
|||||||
Lease termination costs
|
1,185
|
-
|
-
|
|||||||||
Asset impairment expense
|
547
|
291
|
2,791
|
|||||||||
Total operating expenses
|
1,118,577
|
561,044
|
269,822
|
|||||||||
Income (loss) from operations
|
2,229
|
(13,606
|
)
|
(39,136
|
)
|
|||||||
Interest expense
|
(39,017
|
)
|
(12,347
|
)
|
(8
|
)
|
||||||
Loss on early extinguishment or restructuring of debt
|
-
|
(11,969
|
)
|
-
|
||||||||
Gain from contingent value rights valuation
|
-
|
-
|
14,904
|
|||||||||
Other income (expense), net
|
(6,820
|
)
|
702
|
(814
|
)
|
|||||||
Income (loss) from equity investees
|
(3,015
|
)
|
2,665
|
-
|
||||||||
Loss from continuing operations before income taxes
|
(46,623
|
)
|
(34,555
|
)
|
(25,054
|
)
|
||||||
Income tax benefit
|
10,882
|
22,869
|
7,442
|
|||||||||
Loss from continuing operations
|
(35,741
|
)
|
(11,686
|
)
|
(17,612
|
)
|
||||||
Gain (loss) from discontinued operations
|
(21
|
)
|
(146
|
)
|
129,218
|
|||||||
Net income (loss)
|
(35,762
|
)
|
(11,832
|
)
|
111,606
|
|||||||
Less: Net (income) loss attributable to noncontrolling interest
|
197
|
(2,559
|
)
|
-
|
||||||||
Net income (loss) attributable to HC2 Holdings, Inc.
|
(35,565
|
)
|
(14,391
|
)
|
111,606
|
|||||||
Less: Preferred stock dividends and accretion
|
4,285
|
2,049
|
-
|
|||||||||
Net income (loss) attributable to common stock and participating preferred stockholders
|
$
|
(39,850
|
)
|
$
|
(16,440
|
)
|
$
|
111,606
|
||||
Basic income (loss) per common share:
|
||||||||||||
Loss from continuing operations attributable to HC2 Holdings, Inc.
|
$
|
(1.50
|
)
|
$
|
(0.82
|
)
|
$
|
(1.25
|
)
|
|||
Gain (loss) from discontinued operations
|
-
|
(0.01
|
)
|
9.20
|
||||||||
Net income (loss) attributable to HC2 Holdings, Inc.
|
$
|
(1.50
|
)
|
$
|
(0.83
|
)
|
$
|
7.95
|
||||
Diluted income (loss) per common share:
|
||||||||||||
Loss from continuing operations attributable to HC2 Holdings, Inc.
|
$
|
(1.50
|
)
|
$
|
(0.82
|
)
|
$
|
(1.25
|
)
|
|||
Gain (loss) from discontinued operations
|
-
|
(0.01
|
)
|
9.20
|
||||||||
Net income (loss) attributable to HC2 Holdings, Inc.
|
$
|
(1.50
|
)
|
$
|
(0.83
|
)
|
$
|
7.95
|
||||
Weighted average common shares outstanding:
|
||||||||||||
Basic
|
26,482
|
19,729
|
14,047
|
|||||||||
Diluted
|
26,482
|
19,729
|
14,047
|
|||||||||
Dividends declared per basic weighted average common shares outstanding
|
$
|
-
|
$
|
-
|
$
|
8.58
|
|
Years Ended December 31,
|
|||||||||||
|
2015
|
2014
|
2013
|
|||||||||
Cash flows from operating activities:
|
||||||||||||
Net income (loss)
|
$
|
(35,762
|
)
|
$
|
(11,832
|
)
|
$
|
111,606
|
||||
Adjustments to reconcile net income (loss) to operating cash flows:
|
||||||||||||
Provision for doubtful accounts receivable
|
99
|
403
|
1,507
|
|||||||||
Share-based compensation expense
|
11,102
|
11,028
|
2,286
|
|||||||||
Depreciation and amortization
|
30,939
|
10,684
|
23,964
|
|||||||||
Amortization of deferred financing costs
|
1,420
|
240
|
—
|
|||||||||
Lease termination costs
|
1,185
|
—
|
—
|
|||||||||
(Gain) loss on sale or disposal of assets
|
170
|
816
|
(148,848
|
)
|
||||||||
(Gain) loss on sale of investments
|
—
|
(434
|
)
|
—
|
||||||||
Equity investment (income)/loss
|
3,015
|
(2,665
|
)
|
—
|
||||||||
Asset impairment expense
|
547
|
291
|
3,123
|
|||||||||
Amortization of debt discount
|
301
|
1,593
|
86
|
|||||||||
Loss on early extinguishment or restructuring of debt
|
—
|
11,969
|
21,124
|
|||||||||
(Gain) on bargain purchase
|
—
|
(1,417
|
)
|
—
|
||||||||
Unrealized loss on equity securities
|
2,878
|
—
|
—
|
|||||||||
Realized (gains) losses on investments
|
3,175
|
1,608
|
—
|
|||||||||
Change in fair value of Contingent Value Rights
|
—
|
—
|
(14,904
|
)
|
||||||||
Deferred income taxes
|
(13,102
|
)
|
(30,223
|
)
|
(522
|
)
|
||||||
Unrealized foreign currency transaction (gain) loss on intercompany and foreign debt
|
182
|
1,352
|
(764
|
)
|
||||||||
Other
|
5,269
|
—
|
—
|
|||||||||
Changes in assets and liabilities, net of acquisitions:
|
||||||||||||
(Increase) decrease in accounts receivable
|
(60,720
|
)
|
18,349
|
(2,892
|
)
|
|||||||
(Increase) decrease in costs and recognized earnings in excess of billings on uncompleted contracts
|
(11,579
|
)
|
(1,139
|
)
|
—
|
|||||||
(Increase) decrease in inventory
|
2,610
|
6,616
|
644
|
|||||||||
(Increase) decrease in other assets
|
17,032
|
764
|
(2,125
|
)
|
||||||||
Increase (decrease) in life, accident and health reserves
|
608
|
—
|
—
|
|||||||||
Increase (decrease) in accounts payable and other current liabilities
|
36,216
|
18,968
|
(12,859
|
)
|
||||||||
Increase (decrease) in billings in excess of costs and recognized earnings on uncompleted contracts
|
(20,767
|
)
|
(23,793
|
)
|
—
|
|||||||
Increase (decrease) in other liabilities
|
3,259
|
(1,951
|
)
|
(1,741
|
)
|
|||||||
Increase (decrease) in pension liability
|
(10,638
|
)
|
(7,564
|
)
|
—
|
|||||||
Net change in cash due to operating activities
|
(32,561
|
)
|
3,663
|
(20,315
|
)
|
|||||||
Cash flows from investing activities:
|
||||||||||||
Purchases of property, plant and equipment
|
(21,324
|
)
|
(5,819
|
)
|
(12,577
|
)
|
||||||
Sale of property and equipment and other assets
|
5,034
|
3,706
|
9
|
|||||||||
Purchases of investments
|
(54,598
|
)
|
(33,034
|
)
|
—
|
|||||||
Sale of investments
|
12,248
|
2,411
|
—
|
|||||||||
Cash from disposition of business, net of cash disposed
|
—
|
31,645
|
270,634
|
|||||||||
Cash paid for business acquisitions, net of cash acquired
|
39,726
|
(146,026
|
)
|
(397
|
)
|
|||||||
Purchase of noncontrolling interest
|
(475
|
)
|
(38,403
|
)
|
—
|
|||||||
Receipt of dividends from equity investees
|
4,647
|
2,081
|
—
|
|||||||||
(Increase) decrease in restricted cash
|
—
|
(1,785
|
)
|
475
|
||||||||
Net change in cash due to investing activities
|
(14,742
|
)
|
(185,224
|
)
|
258,144
|
|||||||
Cash flows from financing activities:
|
||||||||||||
Annuity receipts
|
78
|
—
|
—
|
|||||||||
Proceeds from long-term obligations
|
564,857
|
915,896
|
—
|
|||||||||
Principal payments on long-term obligations
|
(528,679
|
)
|
(689,745
|
)
|
(128,036
|
)
|
||||||
Payment of fees on restructuring of debt
|
—
|
(12,333
|
)
|
(1,201
|
)
|
|||||||
Proceeds from sale of common stock, net
|
53,975
|
6,000
|
1,158
|
|||||||||
Proceeds from sale of preferred stock, net
|
14,033
|
40,050
|
—
|
|||||||||
Proceeds from the exercise of warrants and stock options
|
—
|
24,348
|
—
|
|||||||||
(Increase) decrease in restricted cash
|
6,014
|
—
|
—
|
|||||||||
Payment of deferred financing costs
|
(1,423
|
)
|
—
|
—
|
||||||||
Payment of dividend equivalents
|
—
|
—
|
(1,235
|
)
|
||||||||
Payment of dividends
|
(5,687
|
)
|
(1,626
|
)
|
(119,788
|
)
|
||||||
Taxes paid in lieu of shares issued for share-based compensation
|
—
|
(47
|
)
|
(1,000
|
)
|
|||||||
Net change in cash due to financing activities
|
103,168
|
282,543
|
(250,102
|
)
|
||||||||
Effects of exchange rate changes on cash and cash equivalents
|
(5,219
|
)
|
(2,001
|
)
|
(1,927
|
)
|
||||||
Net change in cash and cash equivalents
|
50,646
|
98,981
|
(14,200
|
)
|
||||||||
Cash and cash equivalents, beginning of period
|
107,978
|
8,997
|
23,197
|
|||||||||
Cash and cash equivalents, end of period
|
$
|
158,624
|
$
|
107,978
|
$
|
8,997
|
||||||
Supplemental cash flow information:
|
||||||||||||
Cash paid for interest
|
$
|
39,451
|
$
|
7,527
|
$
|
10,372
|
||||||
Cash paid for taxes
|
$
|
1,134
|
$
|
8,792
|
$
|
616
|
||||||
Preferred stock accreting dividends and accretion
|
$
|
206
|
$
|
487
|
$
|
—
|
||||||
Non-cash investing and financing activities:
|
||||||||||||
Capital lease additions
|
$
|
—
|
$
|
—
|
$
|
148
|
||||||
Purchases of property, plant and equipment under financing arrangements
|
$
|
1,808
|
$
|
4,400
|
$
|
—
|
||||||
Property, plant and equipment included in accounts payable
|
$
|
911
|
$
|
2,544
|
$
|
—
|
||||||
Non-cash investing activity on the reacquisition of shares from a noncontrolling interest
|
$
|
—
|
$
|
1,700
|
$
|
—
|
||||||
Conversion of preferred stock to common stock
|
$
|
1,839
|
$
|
—
|
$
|
—
|
||||||
Business acquisition through the issuance of common stock, long-term debt and warrants
|
$
|
11,591
|
$
|
—
|
$
|
—
|
||||||
Non-cash financing activity on issuance of long-term debt
|
$
|
5,000
|
$
|
—
|
$
|
—
|
Twelve Months Ended December 31, 2015
|
||||||||||||||||||||||||||||||||||||||||||||
Core Operating
|
Early Stage and Other
|
Non-operating Corporate
|
HC2
Holdings, Inc. |
|||||||||||||||||||||||||||||||||||||||||
Manufacturing
|
Marine Services
|
Insurance
|
Telecommunications
|
Utilities
|
Total
|
Life
Sciences |
Other
|
Total
|
||||||||||||||||||||||||||||||||||||
Net income (loss)
|
24,451
|
20,855
|
1,327
|
2,779
|
(274
|
)
|
49,139
|
(4,575
|
)
|
(18,276
|
)
|
(22,851
|
)
|
(61,852
|
)
|
(35,565
|
)
|
|||||||||||||||||||||||||||
Adjustments to reconcile net income (loss) to Adjusted EBITDA:
|
-
|
|||||||||||||||||||||||||||||||||||||||||||
Depreciation and amortization
|
2,016
|
17,256
|
2
|
417
|
1,635
|
21,325
|
20
|
1,934
|
1,954
|
-
|
23,280
|
|||||||||||||||||||||||||||||||||
Depreciation and amortization (included in cost of revenue)
|
7,659
|
-
|
-
|
-
|
-
|
7,659
|
-
|
-
|
-
|
-
|
7,659
|
|||||||||||||||||||||||||||||||||
Asset impairment expense
|
-
|
547
|
-
|
-
|
-
|
547
|
-
|
-
|
-
|
-
|
547
|
|||||||||||||||||||||||||||||||||
(Gain) loss on sale or disposal of assets
|
257
|
(138
|
)
|
-
|
50
|
-
|
170
|
-
|
1
|
1
|
-
|
170
|
||||||||||||||||||||||||||||||||
Lease termination costs
|
-
|
-
|
-
|
1,184
|
-
|
1,184
|
-
|
1
|
1
|
-
|
1,185
|
|||||||||||||||||||||||||||||||||
Interest expense
|
1,379
|
3,803
|
-
|
-
|
42
|
5,224
|
-
|
-
|
-
|
33,793
|
39,017
|
|||||||||||||||||||||||||||||||||
Other (income) expense, net
|
(443
|
)
|
(1,340
|
)
|
(56
|
)
|
(2,304
|
)
|
(42
|
)
|
(4,185
|
)
|
(1
|
)
|
5,764
|
5,763
|
5,242
|
6,820
|
||||||||||||||||||||||||||
Foreign currency (gain) loss (included in cost of revenue)
|
-
|
(2,039
|
)
|
-
|
-
|
-
|
(2,039
|
)
|
-
|
-
|
-
|
-
|
(2,039
|
)
|
||||||||||||||||||||||||||||||
Income tax (benefit) expense
|
15,572
|
400
|
(1,448
|
)
|
(237
|
)
|
(347
|
)
|
13,941
|
(1,037
|
)
|
(7,733
|
)
|
(8,770
|
)
|
(16,052
|
)
|
(10,882
|
)
|
|||||||||||||||||||||||||
Loss from discontinued operations
|
20
|
-
|
-
|
-
|
-
|
20
|
-
|
1
|
1
|
-
|
21
|
|||||||||||||||||||||||||||||||||
Noncontrolling interest
|
1,136
|
616
|
-
|
-
|
(267
|
)
|
1,485
|
(1,681
|
)
|
(1
|
)
|
(1,682
|
)
|
-
|
(197
|
)
|
||||||||||||||||||||||||||||
Share-based payment expense
|
-
|
-
|
-
|
-
|
49
|
49
|
71
|
-
|
71
|
10,982
|
11,102
|
|||||||||||||||||||||||||||||||||
Acquisition related costs
|
-
|
-
|
-
|
-
|
70
|
70
|
23
|
-
|
23
|
8,362
|
8,455
|
|||||||||||||||||||||||||||||||||
Other costs
|
-
|
2,181
|
-
|
121
|
-
|
2,302
|
-
|
-
|
-
|
-
|
2,302
|
|||||||||||||||||||||||||||||||||
Adjusted EBITDA
|
$
|
52,047
|
$
|
42,141
|
$
|
(175
|
)
|
$
|
2,010
|
$
|
866
|
$
|
96,889
|
$
|
(7,180
|
)
|
$
|
(18,309
|
)
|
$
|
(25,489
|
)
|
$
|
(19,525
|
)
|
$
|
51,875
|
Three Months Ended December 31, 2015
|
||||||||||||||||||||||||||||||||||||||||||||
Core Operating
|
Early Stage and Other
|
Non-operating Corporate
|
HC2
Holdings,
Inc.
|
|||||||||||||||||||||||||||||||||||||||||
Manufacturing
|
Marine Services
|
Insurance
|
Telecommunications
|
Utilities
|
Total
|
Life
Sciences
|
Other
|
Total
|
||||||||||||||||||||||||||||||||||||
Net income (loss)
|
8,269
|
2,891
|
1,618
|
3,078
|
55
|
15,911
|
(545
|
)
|
(24,044
|
)
|
(24,589
|
)
|
(2,762
|
)
|
(11,440
|
)
|
||||||||||||||||||||||||||||
Adjustments to reconcile net income (loss) to Adjusted EBITDA:
|
||||||||||||||||||||||||||||||||||||||||||||
Depreciation and amortization
|
526
|
4,279
|
2
|
123
|
429
|
5,358
|
12
|
1,292
|
1,305
|
-
|
6,663
|
|||||||||||||||||||||||||||||||||
Depreciation and amortization (included in cost of revenue)
|
1,924
|
-
|
-
|
-
|
-
|
1,924
|
-
|
-
|
-
|
-
|
1,924
|
|||||||||||||||||||||||||||||||||
Asset impairment expense
|
-
|
547
|
-
|
-
|
-
|
547
|
-
|
(0
|
)
|
(0
|
)
|
-
|
547
|
|||||||||||||||||||||||||||||||
(Gain) loss on sale or disposal of assets
|
326
|
(21
|
)
|
-
|
-
|
-
|
305
|
-
|
1
|
1
|
-
|
305
|
||||||||||||||||||||||||||||||||
Lease termination costs
|
-
|
-
|
-
|
60
|
-
|
60
|
-
|
1
|
1
|
-
|
61
|
|||||||||||||||||||||||||||||||||
Interest expense
|
315
|
914
|
-
|
-
|
10
|
1,239
|
-
|
(0
|
)
|
(0
|
)
|
8,570
|
9,809
|
|||||||||||||||||||||||||||||||
Other (income) expense, net
|
(279
|
)
|
(1,090
|
)
|
(56
|
)
|
(2,299
|
)
|
(10
|
)
|
(3,733
|
)
|
(0
|
)
|
6,774
|
6,774
|
251
|
3,292
|
||||||||||||||||||||||||||
Foreign currency (gain) loss (included in cost of revenue)
|
-
|
608
|
-
|
309
|
-
|
916
|
-
|
(1
|
)
|
(1
|
)
|
-
|
915
|
|||||||||||||||||||||||||||||||
Income tax (benefit) expense
|
3,384
|
222
|
(1,448
|
)
|
(237
|
)
|
(347
|
)
|
1,575
|
(1,037
|
)
|
8,616
|
7,579
|
(18,203
|
)
|
(9,048
|
)
|
|||||||||||||||||||||||||||
Loss from discontinued operations
|
0
|
-
|
-
|
-
|
-
|
0
|
-
|
(23
|
)
|
(23
|
)
|
-
|
(23
|
)
|
||||||||||||||||||||||||||||||
Noncontrolling interest
|
169
|
52
|
-
|
-
|
43
|
265
|
(468
|
)
|
(1
|
)
|
(469
|
)
|
-
|
(205
|
)
|
|||||||||||||||||||||||||||||
Share-based payment expense
|
-
|
-
|
0
|
-
|
26
|
26
|
71
|
(0
|
)
|
71
|
3,602
|
3,700
|
||||||||||||||||||||||||||||||||
Acquisition related costs
|
-
|
-
|
-
|
-
|
70
|
70
|
23
|
0
|
23
|
3,660
|
3,754
|
|||||||||||||||||||||||||||||||||
Other costs
|
-
|
2,181
|
-
|
12
|
-
|
2,193
|
-
|
-
|
-
|
-
|
2,193
|
|||||||||||||||||||||||||||||||||
Adjusted EBITDA
|
$
|
14,634
|
$
|
10,585
|
$
|
116
|
$
|
1,046
|
$
|
274
|
$
|
26,655
|
$
|
(1,944
|
)
|
$
|
(7,383
|
)
|
$
|
(9,327
|
)
|
$
|
(4,882
|
)
|
$
|
12,446
|
As Reported
|
Pro Forma
|
|||||||||||||||||||||||||||||||||||||||||||||||
Twelve Months Ended December 31, 2014
|
||||||||||||||||||||||||||||||||||||||||||||||||
HC2 Holdings, Inc.
|
Core Operating
|
Early Stage and Other
|
Non-operating Corporate
|
HC2
Holdings, Inc. |
||||||||||||||||||||||||||||||||||||||||||||
Manufacturing
|
Marine Services
|
Insurance
|
Telecommunications
|
Utilities
|
Total
|
Life
Sciences |
Other
|
Total
|
||||||||||||||||||||||||||||||||||||||||
Net income (loss)
|
(14,391
|
)
|
19,278
|
17,718
|
-
|
(1,068
|
)
|
236
|
36,164
|
(3,759
|
)
|
29,219
|
25,460
|
(51,410
|
)
|
10,214
|
||||||||||||||||||||||||||||||||
Adjustments to reconcile net income (loss) to Adjusted EBITDA:
|
||||||||||||||||||||||||||||||||||||||||||||||||
Depreciation and amortization
|
6,334
|
4,139
|
14,776
|
-
|
528
|
484
|
19,927
|
1
|
-
|
1
|
-
|
19,928
|
||||||||||||||||||||||||||||||||||||
Depreciation and amortization (included in cost of revenue)
|
4,350
|
4,350
|
-
|
-
|
-
|
-
|
4,350
|
-
|
-
|
-
|
-
|
4,350
|
||||||||||||||||||||||||||||||||||||
Asset impairment expense
|
291
|
-
|
-
|
-
|
291
|
-
|
291
|
-
|
-
|
-
|
-
|
291
|
||||||||||||||||||||||||||||||||||||
(Gain) loss on sale or disposal of assets
|
(162
|
)
|
(2
|
)
|
104
|
-
|
(160
|
)
|
-
|
(58
|
)
|
-
|
-
|
-
|
-
|
(58
|
)
|
|||||||||||||||||||||||||||||||
Lease termination costs
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||||||||||||||
Interest expense
|
12,347
|
1,627
|
4,708
|
-
|
1
|
20
|
6,356
|
-
|
-
|
-
|
10,700
|
17,056
|
||||||||||||||||||||||||||||||||||||
Loss on early extinguishment of debt
|
11,969
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
11,969
|
11,969
|
||||||||||||||||||||||||||||||||||||||
Other (income) expense, net
|
(702
|
)
|
(476
|
)
|
(2,410
|
)
|
-
|
(831
|
)
|
(1,431
|
)
|
(5,148
|
)
|
-
|
1,610
|
1,610
|
217
|
(3,321
|
)
|
|||||||||||||||||||||||||||||
Foreign currency (gain) loss (included in cost of revenue)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||||||||||||||
Income tax (benefit) expense
|
(22,869
|
)
|
13,318
|
1,069
|
-
|
58
|
103
|
14,548
|
-
|
(31,828
|
)
|
(31,828
|
)
|
(963
|
)
|
(18,243
|
)
|
|||||||||||||||||||||||||||||||
Loss from discontinued operations
|
146
|
35
|
3,007
|
-
|
-
|
-
|
3,042
|
-
|
157
|
157
|
3,199
|
|||||||||||||||||||||||||||||||||||||
Noncontrolling interest
|
2,559
|
3,569
|
3,059
|
-
|
-
|
229
|
6,857
|
(1,038
|
)
|
1
|
(1,037
|
)
|
-
|
5,820
|
||||||||||||||||||||||||||||||||||
Share-based payment expense
|
11,028
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
11,028
|
11,028
|
||||||||||||||||||||||||||||||||||||
Acquisition related costs
|
13,044
|
-
|
7,966
|
-
|
-
|
-
|
7,966
|
-
|
-
|
-
|
5,078
|
13,044
|
||||||||||||||||||||||||||||||||||||
Other costs
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||||||||||||||
Adjusted EBITDA
|
23,944
|
$
|
45,838
|
$
|
49,997
|
$
|
-
|
$
|
(1,181
|
)
|
$
|
(359
|
)
|
$
|
94,295
|
$
|
(4,796
|
)
|
$
|
(841
|
)
|
$
|
(5,637
|
)
|
$
|
(13,381
|
)
|
$
|
75,277
|